Department of Urology, University of Ulm, Ulm, Germany.
J Urol. 2011 Jun;185(6):2207-12. doi: 10.1016/j.juro.2011.02.006. Epub 2011 Apr 16.
We analyzed the long-term complications (greater than 90 days postoperatively) in a large, single center series of patients who underwent cystectomy and substitution with an ileal neobladder.
A total of 1,540 radical cystectomies were performed at our center between January 1986 and September 2008. Of the patients 1,013 received an ileal neobladder. Only the 923 patients with followup longer than 90 days (median 72 months, range 3 to 267) were included in analysis. All long-term complications were identified. The complication rate was calculated using the Kaplan-Meier method.
The overall survival rate was 65.5%, 49.8% and 28.3% at 5, 10 and 20 years, respectively. The overall long-term complication rate was 40.8% with 3 neobladder related deaths. Hydronephrosis, incisional hernia, ileus or small bowel obstruction and feverish urinary tract infection were observed in 16.9%, 6.4%, 3.6% and 5.7% of patients, respectively, 20 years postoperatively. Subneovesical obstruction in 3.1% of cases was due to local tumor recurrence in 1.1%, neovesicourethral anastomotic stricture in 1.2% and urethral stricture in 0.9%. Chronic diarrhea was noted in 9 patients. Vitamin B12 was substituted in 2 patients. Episodes of severe metabolic acidosis occurred in 11 patients and 307 of 923 required long-term bicarbonate substitution. Rare complications included cutaneous neobladder fistulas in 2 cases, and intestinal neobladder fistulas, iatrogenic neobladder perforation, spontaneous perforation and necrotizing pyocystis in 1 each.
Even in experienced hands the long-term complication rate of radical cystectomy and neobladder formation are not negligible. Most complications are diversion related. The challenge of optimum care for these elderly patients with comorbidities is best mastered at high volume hospitals by high volume surgeons.
我们分析了在一个大型单中心系列接受膀胱切除术和回肠新膀胱替代的患者中,长期并发症(术后 90 天以上)。
1986 年 1 月至 2008 年 9 月,我们中心共进行了 1540 例根治性膀胱切除术。其中 1013 例患者接受了回肠新膀胱。仅对随访时间超过 90 天(中位数 72 个月,范围 3 至 267)的 923 例患者进行分析。所有长期并发症均已确定。使用 Kaplan-Meier 方法计算并发症发生率。
5 年、10 年和 20 年的总生存率分别为 65.5%、49.8%和 28.3%。整体长期并发症发生率为 40.8%,3 例新膀胱相关死亡。术后 20 年,分别有 16.9%、6.4%、3.6%和 5.7%的患者出现肾盂积水、切口疝、肠梗阻或小肠梗阻和发热性尿路感染,3.1%的患者存在亚新膀胱下梗阻,其中 1.1%是由于局部肿瘤复发,1.2%是由于新膀胱尿道吻合口狭窄,0.9%是由于尿道狭窄。9 例患者出现慢性腹泻,2 例患者需要补充维生素 B12。11 例患者出现严重代谢性酸中毒,923 例患者中有 307 例需要长期碳酸氢盐替代治疗。罕见并发症包括 2 例皮肤新膀胱瘘,1 例肠道新膀胱瘘、医源性新膀胱穿孔、自发性穿孔和坏死性脓毒症各 1 例。
即使在经验丰富的医生手中,根治性膀胱切除术和新膀胱形成的长期并发症发生率也不容忽视。大多数并发症与分流术有关。在有合并症的老年患者中,最佳护理的挑战最好由高容量医院的高容量外科医生来掌握。